After two years of research and development, Alife Assist is the company’s first commercial offering. The platform includes tools to make sure clinicians choose the correct medication dose, streamline clinician workflow and monitor the clinic’s performance.
“I founded Alife because I knew that AI has the potential to drastically impact the IVF process. Yet, as we began to work with fertility clinics around the country, we quickly identified a parallel opportunity for improvement: the need for a central platform to digitize clinic workflow and support collective decision making,” Alife CEO Paxton Maeder-York said in the Oct. 24 company news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
